Insulin resistance in patients with depression and its changes during the clinical course of depression: Minimal model analysis

Metabolism: Clinical and Experimental

Volumn 49, Issue 10, 2000, Pages 1255-1260

  Okamura, F ^a   Tashiro, A ^a   Utumi, A ^a   Imai, T ^a   Suchi, T ^a   Tamura, D ^a   Sato, Y ^a   Suzuki, S ^a   Hongo, M ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CLOMIPRAMINE; DOSULEPIN; GLUCOSE; INSULIN; MAPROTILINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOOD INTAKE; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; STATISTICAL ANALYSIS;

EID: 0033787726     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.9515     Document Type: Article

References (49)

1. Prevalence of depression in adults with diabetes. An epidemiological evaluation
2. Depression and risk for onset of type II diabetes. A prospective population-based study
3. Insulin resistance after oral glucose tolerance testing in patients with major depression
4. Hyper-insulin response in a patient with depression. Changes in insulin resistance during recovery from depression
5. Relative insulin insensitivity and cortisol secretion in depressed patients
6. Toward physiological understanding of glucose tolerance. Minimal-model approach
7. Insulin resistance in patients with depression and its changes in the clinical course of depression: A report on three cases using the minimal model analysis
8. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp
9. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
10. A rating scale for depression
11. Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity
12. Usefulness of fluoxetine in obese non-insulin-dependent diabetics: A multicenter study
13. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss
14. Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients
15. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes
16. Direct comparison of standard and insulin modified protocols for minimal model estimation of insulin sensitivity in normal subjects
17. Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans
18. The Hamilton Depression Rating Scale in normals and depressives
19. Validity of the Hamilton Rating Scale for Depression
20. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus
21. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus
22. Psychological and social correlates of glycemic control
23. Pharmacotherapy of depression may improve both mood and glucose regulation in diabetes
24. Relationship of self-efficacy and binging to adherence to diabetes regimen among adolescents
25. Appetite and food preference in depression: Effects of imipramine treatment
26. Eating behaviour and depression before and after antidepressant treatment: A prospective, naturalistic study
27. Habitual dietary intake and insulin sensitivity in lean and obese adults
28. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men
29. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR)
30. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep
31. Effects of exercise on insulin sensitivity in humans
32. Weight gain. A side-effect of tricyclic antidepressants
33. Treatment of depression in patients with diabetes mellitus
34. Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial
35. Neuroendocrine interrelationships in major depressive disorder
36. Growth hormone-releasing factor stimulation test in depression
37. Psychiatric aspects of Cushing's syndrome
38. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: A minimal model analysis
39. Insulin resistance in Cushing's syndrome
40. Serotonergic dysfunction in depression
41. Serotonin and its place in the pathogenesis of depression
42. Role of insulin resistance in human disease (syndrome X): An expanded definition
43. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
44. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study
45. Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity
46. Depression as a risk factor for ischaemic heart disease in men: Population based case-control study
47. Depression is a risk factor for coronary artery disease in men: The Precursors Study
48. Depressive symptoms and increased risk of stroke mortality over a 29-year period